These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15692061)

  • 1. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.
    Esplugues E; Vega-Ramos J; Cartoixà D; Vazquez BN; Salaet I; Engel P; Lauzurica P
    Blood; 2005 Jun; 105(11):4399-406. PubMed ID: 15692061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor immunity in mice deficient in CD69.
    Esplugues E; Sancho D; Vega-Ramos J; Martínez C; Syrbe U; Hamann A; Engel P; Sánchez-Madrid F; Lauzurica P
    J Exp Med; 2003 May; 197(9):1093-106. PubMed ID: 12732655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
    Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
    Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.
    Zhao L; Gao X; Peng Y; Joyee AG; Bai H; Wang S; Yang J; Zhao W; Yang X
    Immunology; 2011 Oct; 134(2):172-84. PubMed ID: 21896012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD69 Targeting Enhances Anti-vaccinia Virus Immunity.
    Notario L; Redondo-Antón J; Alari-Pahissa E; Albentosa A; Leiva M; Lopez D; Sabio G; Lauzurica P
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.
    Clausen J; Vergeiner B; Enk M; Petzer AL; Gastl G; Gunsilius E
    Immunobiology; 2003; 207(2):85-93. PubMed ID: 12675266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15 activated bovine natural killer cells express CD69 and produce interferon-γ.
    Lund H; Boysen P; Dean GA; Davis WC; Park KT; Storset AK
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):79-89. PubMed ID: 23021353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide from
    Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus directly activates murine NK cells via TLR9.
    Moriyama T; Suzuki T; Chang MO; Kitajima M; Takaku H
    Cancer Gene Ther; 2017 Apr; 24(4):175-179. PubMed ID: 28186087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 targeting differentially affects the course of collagen-induced arthritis.
    Sancho D; Gómez M; Martinez Del Hoyo G; Lamana A; Esplugues E; Lauzurica P; Martinez-A C; Sánchez-Madrid F
    J Leukoc Biol; 2006 Dec; 80(6):1233-41. PubMed ID: 16921025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
    Hamm S; Rath S; Michel S; Baumgartner R
    J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.
    Hatfield SD; Daniels KA; O'Donnell CL; Waggoner SN; Welsh RM
    Virology; 2018 Jun; 519():131-144. PubMed ID: 29715623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
    Jewett A; Teruel A; Romero M; Head C; Cacalano N
    Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
    Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.
    Notario L; Alari-Pahissa E; de Molina A; Lauzurica P
    J Virol; 2016 Jul; 90(14):6464-6474. PubMed ID: 27147744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.
    Blake SJ; Stannard K; Liu J; Allen S; Yong MC; Mittal D; Aguilera AR; Miles JJ; Lutzky VP; de Andrade LF; Martinet L; Colonna M; Takeda K; Kühnel F; Gurlevik E; Bernhardt G; Teng MW; Smyth MJ
    Cancer Discov; 2016 Apr; 6(4):446-59. PubMed ID: 26787820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.